Stephens Consulting, LLC Kempharm, Inc Transaction History

Stephens Consulting, LLC

  • $400 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
N/A
-1,000 Reduced 50.0%
1,000 $4.9 Million
Q1 2022

Jan 19, 2023
SELL
$5.0 - $9.26 $1,125 - $2,083
-225 Reduced 10.11%
2,000 $10.1 Million
Q4 2021

Jan 19, 2023
BUY
$7.6 - $10.26 $16,910 - $22,828
2,225 New
2,225 $19.4 Million

About KEMPHARM, INC

KMPH Quotes by TradingView
  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Stephens Consulting, LLC Portfolio

Follow Stephens Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email